eFFECTOR Therapeutics Inc

NASDAQ:EFTR   3:59:51 PM EDT
10.35
-0.26 (-2.45%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

eFFECTOR Therapeutics Inc Stock, NASDAQ:EFTR

11120 Roselle Street, Suite A, San Diego, California 92121
United States of America
Phone: +1.858.925.8215
Number of Employees: 13

Description

eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2). The company was founded by Kevan Shokat, Davide Ruggero, and Siegfried Reich on May 1, 2012 and is headquartered in San Diego, CA.